Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on: January 22,2024

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on:January 22,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on: January 03,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on:January 03,2024

Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

byGarvan Institute of Medical ResearchFluorescent image of cancer cells (cell nuclei in blue) stockpiling lipids in the form of lipid droplets (in red). The researchers showed these lipid drople

Updated on: April 28,2024

Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

byGarvan Institute of Medical ResearchFluorescent image of cancer cells (cell nuclei in blue) stockpiling lipids in the form of lipid droplets (in red). The researchers showed these lipid drople

Updated on:April 28,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on: August 28,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on:August 28,2024

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on: May 23,2024

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on:May 23,2024

Key immune cells maintain healthy gut bacteria to protect against colorectal cancer

by Weill Cornell Medical CollegeArtistic rendering of a tumor growing within a colon, resulting in local alterations of resident microbiota. Credit: Sarah Field SonnenbergAn immune cell subset ca

Updated on: June 17,2024

Key immune cells maintain healthy gut bacteria to protect against colorectal cancer

by Weill Cornell Medical CollegeArtistic rendering of a tumor growing within a colon, resulting in local alterations of resident microbiota. Credit: Sarah Field SonnenbergAn immune cell subset ca

Updated on:June 17,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on: March 27,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on:March 27,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on: October 21,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on:October 21,2024

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on: April 09,2024

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on:April 09,2024

Genetic testing is important for women with breast cancer, expert says

by Rebecca Biason,University of TorontoCredit: Pixabay/CC0 Public DomainFor close to two decades Professor Kelly Metcalfe, a senior scientist at Women's College Research Institute and associ

Updated on: January 21,2024

Genetic testing is important for women with breast cancer, expert says

by Rebecca Biason,University of TorontoCredit: Pixabay/CC0 Public DomainFor close to two decades Professor Kelly Metcalfe, a senior scientist at Women's College Research Institute and associ

Updated on:January 21,2024

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on: June 28,2024

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on:June 28,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on: January 30,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on:January 30,2024